Clinical study of bacteriophage in prevention and control of nosocomial transmission of multidrug-resistant Acinetobacter baumannii

Status

Active, not recruiting

Phases

Early Phase 1

Study type

Interventional

Source

ChiCTR

Registry ID

ChiCTR2000037365

Enrollment

Unknown

Registered

2020-08-28

Start date

2021-01-01

Completion date

Unknown

Last updated

2020-10-19

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

nosocomial transmission of multidrug-resistant bacteria

Interventions

Phage application:Environmental phage spraying

Eligibility

Sex/Gender

All

Age

18 Years to 90 Years

Inclusion criteria

Inclusion criteria: (1) Carbapenem-resistant baumannii (CRAB) were detected in the ward where the subject (aged 18-90 years old) hospitalized; (2) At least one lytic phage against the target CRAB can be screened from our phage bank; (3) The subject and his/her guardian are fully read, understand and sign the informed consent statement.

Exclusion criteria

Exclusion criteria: (1) There's patient who do not want to receive phage spraying in the room; (2) There's patient who is intolerance with environmental phage atomization in the room.

Design outcomes

Primary

Measure	Time frame
Bacterial isolation, Semi-quantification;Incidence of CRAB isolation;	—

Secondary

Measure	Time frame
Phage-typing;Consumption of high-grade antibiotics;	—

Countries

China

Contacts

Public ContactWu Nannan

Shanghai Public Health Clinical Center

wunannan@shphc.org.cn+86 18121150989

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026